BIOTEST AG

In News

BIO.DE Biotest AG on XETRA pre-market: €42.20 shows oversold bounce opportunity - Meyka

Meyka - Jan 24, 2026

Grifols’ Biotest wins first regulatory approval for its fibrinogen concentrate - The Pharma Letter

The Pharma Letter - Nov 13, 2025

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange - Ashurst

Ashurst - Jun 12, 2025

Osborne Clarke advises Grifols on delisting offer and delisting from stock exchange of Biotest - Osborne Clarke

Osborne Clarke - Jun 16, 2025

BIO.DE Biotest AG XETRA 15 Jan 2026: Oversold bounce from €42.20, watch €43.50 - Meyka

Meyka - Jan 15, 2026

Grifols’ Biotest to launch Yimmugo in USA - The Pharma Letter

The Pharma Letter - Oct 10, 2025

Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US - PR Newswire

PR Newswire - Oct 02, 2024

Grifols launches a €350 million takeover bid for its subsidiary Biotest. - Diari ARA

Diari ARA - Mar 31, 2025

Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA Approval - BioSpace

BioSpace - Jul 01, 2024

Creat Explores Options for German Blood Plasma Firm Biotest - Bloomberg

Bloomberg - Jun 01, 2021

Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease - Wiley Online Library

Wiley Online Library - Aug 09, 2022

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors - Business Wire

Business Wire - Nov 08, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment